Armodafinil
From Wikipedia, the free encyclopedia
 |
|
|
Armodafinil
|
|
| Systematic (IUPAC) name | |
| (-)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide | |
| Identifiers | |
| CAS number | |
| ATC code | N06 |
| PubChem | ? |
| Chemical data | |
| Formula | C15H15NO2S |
| Mol. mass | 273.351 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic, including CYP3A4 and other pathways |
| Half life | 12-15 hrs |
| Excretion | Urine (as metabolites) |
| Therapeutic considerations | |
| Pregnancy cat. |
C |
| Legal status |
Schedule IV (USA) |
| Routes | Oral |
Armodafinil (Nuvigil®) is an eugeroic drug produced by the pharmaceutical company Cephalon Inc., currently in the process of receiving Food and Drug Administration (FDA) approval. Armodafinil is the r-enantiomer of modafinil, so is expected to act in a similar manner, with similar effects. However, it acts for a longer duration of time than modafinil. Upon approval, it is expected to be classified as a Schedule IV controlled substance.
[edit] See also
[edit] External links
Adrafinil, Amphetamine (speed), Armodafinil, Caffeine, Cocaine, Ephedrine, Epinephrine (adrenaline), MDMA, Methylphenidate, Modafinil, Nicotine
See also Sympathomimetic amines
 |
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
